Esperion Therapeutics | Dochód Netto

Cena Akcji
3.49
Dzienna Zmiana
0.10 2.80%
Miesięcznie
-1.83%
Rocznie
85.37%
Q1 Prognozy TE
2.70




Dochód Netto Zmiana Data
AbbVie USD 1.82B 1.63B 2025-12
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
Amarin USD -7.74M 6.4M 2025-09
Amgen USD 1.33B 1.88B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Cipla INR 6.76B 6.75B 2025-12
CSL USD 497.5M 1.51B 2025-06
Cytokinetics USD -306.18M 171.81M 2025-09
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Geron USD -18.43M 2.05M 2025-09
Grifols EUR 148.4M 15.76M 2025-09
Halozyme Therapeutics USD 175.22M 10.06M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Merck USD 2.96B 2.82B 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Moderna USD -200M 625M 2025-09
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD 15.9M 80.75M 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
United Therapeutics USD 338.7M 29.2M 2025-09
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12


Esperion Therapeutics Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.